Monday, July 24, 2017

Arzeda Gets $12M For Bioengineering Tools

Seattle-based Arzeda, a developer of computational, protein design and bioengineering tools, has raised $12M in a Series A funding, the company said last week. The funding was led by OS Fund, and also included Bioeconomy Capital, Sustainable Conversion Ventures, and WRF Capital. The company is applying bioengineering to modify yeast for industry-scale, chemical production.